Author:
Afzal-Shah Mariya,Villar Hugo E.,Livermore David M.
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference19 articles.
1. Joly-Guillo, M. L., Vallee, E., Bergogne-Berezin, E. & Philippon, A. 1988 Distribution of β-lactamases and phenotype analysis in clinical strains of Acinetobacter calcoaceticus. Journal of Antimicrobial Chemotherapy, 22, 597–604.
2. Bergogne-Berezin, E. & Towner, K. J.1996Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clinical Microbiology Reviews, 9,148–65.
3. Paton, R. H., Miles, S., Hood, J. & Amyes, S. G. B.1993 ARI-1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii International Journal of Antimicrobial Agents, 2, –818.
4. Brown, S., Bantar, C., Young, H. K. & Amyes, S. G. B.1997 Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2. Lancet, 351, 186–7.
5. Afzal-Shah, M. & Livermore, D. M.1998Worldwide emergence of carbapenem-resistant Acinetobacter spp. Journal of Antimicrobial Chemotherapy, 41, 576–7
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献